AstraZeneca PLC Plans to Delist Indian Arm, AstraZeneca Pharma India Ltd.

SCRIP -- The board of AstraZeneca Pharma India has approved a proposal from its parent company, AstraZeneca Pharma AB, to delist the shares of the Indian arm from local bourses.

MORE ON THIS TOPIC